A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications

• Main Authors: Merlin Wennmann (Author), Simone Kathemann (Author), Kristina Kampmann (Author), Sinja Ohlsson (Author), Anja Büscher (Author), Dirk Holzinger (Author), Adela Della Marina (Author), Elke Lainka (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Rituximab (RTX) is used in cancer therapy as well as in the treatment of autoimmune diseases and alloimmune responses after transplantation. It depletes the disease-causing B cells by binding to the CD (cluster of differentiation) 20 antigen. We evaluate different pediatric treatment pro...